DAIC

MARCH 19, 2024

Getty Images milla1cf Tue, 03/19/2024 - 19:09 March 19, 2024 — The American College of Cardiology ( ACC ) has selected 50 learners for its 2024 – 2025 Clinical Trials Research (CTR) program , of whom 28 structural heart cardiologists and surgeons will participate in the CTR’s new Project REACH.

Research 105

Research Heart Disease Hospital Private Practice 105

ADN Center of Excellence

NOVEMBER 14, 2024

Research and Leadership Opportunities Fellowships often integrate research components, enabling participants to contribute to the academic and scientific community. Oncology Oncology fellowships delve into cancer care, focusing on advancements in chemotherapy, immunotherapy, and targeted treatments.

Academic 59

Academic Interventional Cardiology Private Practice Innovation 59

Medical Xpress - Cardiology

JULY 11, 2024

New research from the University of Alberta offers the hope of better long-term outcomes for survivors of childhood cancer—and the path to those better outcomes is exercise.

Cancer 40

Cancer Research Exercise Outcomes 40

Society of Thoracic Surgeons - Surgeon

OCTOBER 15, 2024

The esophagectomy for cancer risk calculator is powered by enhanced STS esophagectomy for cancer risk models using data from 18,503 patients across 254 hospitals between January 2015 and December 2022. Key updates include the incorporation of new risk factors such as preoperative cancer staging and body surface area.

Cancer 52

Cancer Risk Factors Hospital Research 52

DAIC

APRIL 9, 2024

Anthracyclines are a well-established class of cancer drugs that are used to treat several types of cancer. While they are effective at eradicating cancer, they are known to carry a risk of causing damage to the heart muscle. of those who received enalapril and 83.3% of those receiving standard of care.

ACE Inhibitor 105

ACE Inhibitor Cancer Biomarkers Heart Failure 105

Journal of Cardiothoracic Surgery

FEBRUARY 3, 2024

Early-stage esophageal cancer is treated using endoscopic submucosal dissection and esophagectomy. Field cancerization in patients with early-stage esophageal cancer affects treatment outcomes and causes synch.

Cancer 52

Cancer Outcomes Research 52

Society of Thoracic Surgeons - Research

FEBRUARY 5, 2024

Preserve Medical Research Funding gtrainyte Mon, 02/05/2024 - 10:50 Scroll to top Preserve Medical Research Funding Supporting investments into research funding that enables surgeons to explore innovative techniques, cutting-edge technologies, and novel therapies that can revolutionize the diagnosis and treatment of thoracic diseases.

Research 40

Research Cancer Cardiothoracic Innovation 40

Journal of Cardiothoracic Surgery

DECEMBER 19, 2024

The prognosis of patients with synchronous oligometastatic non-small cell lung cancer (NSCLC) has been improving owing to advancements in imaging techniques and new treatment approaches such as tyrosine kinase.

Cancer 52

Cancer Outcomes Research 52

Circulation

NOVEMBER 11, 2024

Background:Cardiovascular disease is an important cause for mortality in cancer patients and cancer is a primary cause of non- cardiac mortality in patients with heart failure. Patients with a principal discharge diagnosis of heart failure were stratified into two groups based on presence of cancer. vs 3.1%; OR: 1.6;

Heart Failure 40

Heart Failure Cancer Hospital Outcomes 40

DAIC

MAY 1, 2024

When did the patient arrive, when was a CT scan performed, when was the first puncture, when could the blood flow be restored, During mechanical thrombectomy, a range of data must be recorded in the patient report and then manually transferred to various registers for the clinical outcome and for prospective studies.

Strokes 105

Strokes Stroke Blood Clot Research 105

Heart BMJ

NOVEMBER 27, 2023

The number of patients at the intersection of cancer and cardiovascular disease (CVD) is increasing, reflecting ageing global populations, rising burden of shared cardiometabolic risk factors, and improved cancer survival. Many cancer treatments carry a risk of cardiotoxicity.

Cardio Oncology 40

Cardio Oncology Cancer Cardiovascular Disease Risk Factors 40

DAIC

FEBRUARY 21, 2024

In America, pediatric heart failure results in more than 14,000 hospitalizations annually, outnumbering pediatric cancer. Yet, research and innovation in this field has not kept pace. As a united force, the group is dedicated to improving outcomes and enhancing the quality of life for young heart failure patients.

Pediatrics 105

Pediatrics Hospital Heart Failure Transplant 105

Journal of the American Heart Association

JANUARY 31, 2024

Arrests involving patients <18 years, health care facility residents, patients with cancer diagnoses, and patients with select missing data were excluded. Our main outcome of interest was survival with good neurological outcome, defined as Cerebral Performance Category score 1 or 2. versus non‐OD: 23.5%,P=0.087)

Cardiac Arrest 80

Cardiac Arrest Public Health Cancer Hospital 80

Cardiometabolic Health Congress

JANUARY 30, 2024

Dr. Hallberg passed in March of 2022 after a 5-year battle with stage IV lung cancer. Research now suggests the potential for diabetes reversal through other means that have only recently been embraced in official guidelines. hour live, complimentary legacy course in honor of the late Dr. Sarah Hallberg.

Webinar 105

Webinar Diabetes Education Diet 105

Journal of Cardiothoracic Surgery

FEBRUARY 4, 2025

Today, pneumonectomy is primarily indicated for non-small cell lung cancer (NSCLC) wor. Pneumonectomy, the surgical removal of an entire lung, was first performed in 1933 by Evarts A. Graham for lung carcinoma.

Cancer 52

Cancer Outcomes Research 52

DAIC

JANUARY 12, 2024

a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, announced that positive results from its Phase 3 ATTRibute-CM study of acoramidis for patients with ATTR-CM were published in the New England Journal of Medicine (NEJM). milla1cf Fri, 01/12/2024 - 13:23 January 12, 2024 — BridgeBio Pharma, Inc. ,

Cardiomyopathy 105

Cardiomyopathy Medicare Cancer Hospital 105

Journal of Cardiothoracic Surgery

JANUARY 26, 2025

Sarcomas are rare cancers originating from mesenchymal tissues, manifesting in diverse anatomical locations, but notably in connective tissue, muscles and the skeleton. Thoracic sarcomas present a unique diagn.

Cardiothoracic 52

Cardiothoracic Cancer Outcomes Research 52

Circulation

NOVEMBER 11, 2024

The primary outcome was to estimate the prevalence of cardiovascular risk factors in patients with hemophilia compared to the general population. Further research is to identify potential ex-specific risk factors that predispose to worse cardiovascular outcomes among patients with hemophilia.

Risk Factors 40

Risk Factors Cardiovascular Disease Coronary Artery Bypass Graft Outcomes 40

DAIC

FEBRUARY 29, 2024

Five highly-anticipated late-breaking clinical trial sessions, an ACC/AHA guidelines update session and a host of featured clinical research sessions have been announced by program planners for the American College of Cardiology’s 73 rd Annual Scientific Session & Expo to be held April 6-8 in Atlanta, GA.

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

DAIC

MARCH 31, 2025

in the very high risk category (p-trend for ARR "Research shows that 40% of patients with atrial fibrillation are not receiving optimal treatment when it comes to anticoagulation, in large part due to a fear of bleeding. In contrast, the rates of bleeding in patients in the pooled abelacimab arm were 2.5% in the low-risk category to 7.1%

Atrial Fibrillation 52

Atrial Fibrillation BMI General Cardiology Thrombosis 52

Society of Thoracic Surgeons - Congenital

JANUARY 7, 2025

The researchers found that patients who received multi-arterial grafting (MAG) had improved survival over those who received single-arterial grafting (SAG), supporting findings from prior retrospective studies. Dr. Schaffers team was somewhat surprised by the results of our surgeon-preference analysis.

Outcomes 40

Outcomes Cardiothoracic Coronary Artery Bypass Graft Medicare 40

Journal of Cardiovascular Pharmacology

AUGUST 6, 2024

Patients undergoing anthracycline-based cancer treatments have an increased risk of heart failure (HF) and adverse metabolic outcomes such as malnutrition and cachexia. Using the TriNetx research network, we identified 1,545 patients with a history of SGLT2i use and 17,681 without. Copyright © 2024 Wolters Kluwer Health, Inc.

Heart Failure 40

Heart Failure Cancer Research Outcomes 40

Physiologically Speaking

DECEMBER 27, 2023

The quest to determine whether plant-based diets surpass omnivorous diets in their heart healthfulness has been ongoing for decades, yielding inconclusive results despite dedicated research endeavors. Recent research underscores the critical role of gene-nutrient interactions — so-called nutrigenomics.

Diet 69

Diet Cardiovascular Disease Research Diabetes 69

Journal of Cardiothoracic Surgery

DECEMBER 7, 2023

Frailty develops as a result of age-related decline in many physiological systems and is associated with increased vulnerability to adverse outcomes following thoracic surgery. We prospectively tested our hypo.

Cancer 40

Cancer Physiology Pulmonary Outcomes 40

Physiologically Speaking

DECEMBER 27, 2023

The quest to determine whether plant-based diets surpass omnivorous diets in their heart healthfulness has been ongoing for decades, yielding inconclusive results despite dedicated research endeavors. Recent research underscores the critical role of gene-nutrient interactions — so-called nutrigenomics.

Diet 52

Diet Cardiovascular Disease Research Diabetes 52

Physiologically Speaking

OCTOBER 9, 2024

Researchers claim to have discovered “exercise in a pill” every few years, like clockwork. It also strengthens bones, enhances joint flexibility, and even improves sleep—outcomes that can’t be achieved simply by boosting lactate or BHB levels. At its core, exercise is a whole-body experience.

Exercise 75

Exercise Physiology Diet Obesity 75

MIBHS

SEPTEMBER 29, 2023

A weak immune system will not be able to fight infections or cancer cells nearly as well as a strong immune system. Improved Outcomes : Research suggests that patients who undergo bloodless heart surgery may experience improved outcomes in terms of shorter hospital stays and faster recovery times.

Open-Heart Surgery 52

Open-Heart Surgery Circulation Cancer Hospital 52

Physiologically Speaking

JANUARY 26, 2024

However, there’s not great evidence that multivitamins benefit specific health outcomes. This hypothesis was studied in a randomized controlled trial known as the COcoa Supplement and Multivitamin Outcomes Study or COSMOS. Nutritional insurance? A health- and longevity-boosting powerhouse? Perhaps not.

Physiology 52

Physiology Diet Cardiovascular Disease BMI 52

Dr. Smith's ECG Blog

APRIL 21, 2023

ECGs labeled ‘normal’ Initially the patient had been on the medical wards for cancer treatment, and had been noted to have on/off chest pain with a troponin I that was mildly elevated around the 300 ng/L range. The reason for this patient's admission to the hospital the day before was for cancer treatment.

Chest Pain 52

Chest Pain STEMI Cancer Hemorrhage 52

DAIC

MAY 8, 2024

Bioelectronic medicine scientists at The Feinstein Institutes for Medical Research used noninvasive, splenic focused ultrasound stimulation (sFUS) and found they can reduce inflammation and improve symptoms of pulmonary arterial hypertension (PAH). In pioneering research led by Kevin J.

Ultrasound 115

Ultrasound Pulmonary Research Hypertension 115

Society of Thoracic Surgeons - Congenital

JANUARY 25, 2025

The study, leveraging data from the STS Adult Cardiac Surgery Database (ACSD), offers the most comprehensive analysis to date of prosthetic valve outcomes, encompassing over 100,000 patients. The study addressed a critical question in cardiac surgery: how age and valve type influence outcomes for patients undergoing surgical AVR.

Aortic valve 75

Aortic valve Aortic Cardiothoracic Cancer 75

Journal of Clinical Investigation - Cardiology

JULY 15, 2024

A growing body of research has identified circadian-rhythm disruption as a risk factor for metabolic health. These circadian mechanisms represent potential pathophysiological pathways linking circadian disruption to adverse metabolic health outcomes, including obesity, metabolic syndrome, and type 2 diabetes.

Diabetes 111

Diabetes Obesity Cancer Risk Factors 111

DAIC

FEBRUARY 28, 2024

The findings – published this week in the Journal of the American College of Cardiology — could fuel advocacy for a paradigm shift in clinical heart health guidelines to address cardiovascular risk factors at an earlier age in childhood cancer survivors. “We Wendy Bottinor, MD.

Risk Factors 105

Risk Factors Cancer Cardio Oncology Blood Pressure 105

Dr. Paddy Barrett

OCTOBER 11, 2024

Obesity is the second leading cause of preventable cancers after smoking 9. Anything that reduces obesity has the potential to reduce future risks of any associated cancers. Colorectal Cancer - 46% reduction. Kidney Cancer - 24% reduction. Liver Cancer - 53% reduction. Pancreatic Cancer - 59% reduction.

Obesity 84

Obesity Cancer Dementia Coronary Artery Disease 84

Stroke Journal

JANUARY 30, 2025

Aim:To analyze outcomes in AIS patients with history of cancer after Mechanical thrombectomyIntroduction:Mechanical thrombectomy (MT) is an effective treatment for acute ischemic stroke (AIS) due to large vessel occlusion. Metastatic cancer was significantly associated with higher mortality risk after MT.

Cancer 40

Cancer Strokes Stroke Outcomes 40

DAIC

DECEMBER 5, 2024

With this new funding, Cleerly will continue to scale its commercial growth and clinical evidence generation, helping health care professionals improve outcomes for patients across the coronary care pathway. This is what good software can do in the world!" For more information about Cleerly, please visit www.cleerlyhealth.com.

Coronary Artery Disease 52

Coronary Artery Disease Medicare Plaque Technology 52

Stroke Journal

JANUARY 30, 2025

TAVR seems to be preferred in patients with cancer; however, related research on the clinical efficacy and stroke outcomes of TAVR in patients with cancer is limited. Patients were stratified into two groups: cancer patients 13583 (96.7%) and non-cancer patients 463 (3.3%).

Aortic valve 40

Aortic valve Cancer Aortic Stenosis 40